Coming into today, shares of the biopharmaceutical company had lost 0.56% in the past month. In that same time, the Medical sector gained 4.88%, while the S&P 500 gained 5.97%. Investors will be hoping for strength from BMY as it approaches its next earnings release, which is expected to be July 25, 2019. In that report, analysts expect BMY to post earnings of $1.05 per share. This would mark year-over-year growth of 3.96%. Our most recent consensus estimate is calling for quarterly revenue of $5.98 billion, up 4.82% from the year-ago period.